Episode 36

All Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial)

In the sixth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the different reasons that lead to the end of a trial – especially when it is earlier than planned. He also gives us a summary of what happens after the trial; the importance of some steps involving the data and their availability, and the writing of reports for the appropriate regulatory authorities.

In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map.

It will help you answer interrogations such as:

• What is a CRO?

• How are clinical studies designed?

• Which role(s) should sponsors fulfil?

Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.


Host: Prof. Robert Hills


What did you think of this podcast? Share your opinions with us in this short feedback survey.

Provide Feedback


Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.

https://ehaedu.org/Campus


Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.


Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

Facebook: https://e-h-a.link/facebook

LinkedIn: https://www.linkedin.com/company/eha/

Email us: education@ehaweb.org

Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe 

About the Podcast

Show artwork for EHA Unplugged
EHA Unplugged

Listen for free

About your host

Profile picture for European Hematology Association

European Hematology Association

The European Hematology Association promotes excellence in patient care, research, and education in hematology. We serve medical professionals, researchers, and scientists with an active interest in hematology. We are proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology